Skip to content
PowerCore Vault

Zimbabwe Declines ‘Lopsided’ American Health Aid Deal Due to Information Fears

Health aid illustration
The offered US funding was intended for programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has rejected a major US health deal valued at $367m (£272m) spanning five years because of the United States' request for sensitive information.

This move came to light after a official document from December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the arrangement was "lopsided".

A government spokesperson has since explained that the United States was demanding access to genetic material for research and commercial purposes while refused to guarantee the resulting advantages from future medical innovations.

"We will now turn to the difficult and regrettable process of winding down our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the US had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.

A medical body in Zimbabwe has called for more negotiations to secure a deal acceptable to all parties so the country's critical HIV programme can continue.

Wider Context

This development comes after a similar situation in neighbouring Kenya, where a high court blocked a related deal with the US after legal challenges were filed about the security of Kenyans' health data.

After resuming office last year, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.

USAID had administered aid for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing government-to-government deals to enhance openness and accountability.

Based on statements, 16 African countries have so far agreed to similar health pacts, representing more than $18.3bn of fresh investment.

Details of the Rejected Agreement

This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this cooperation might have yielded significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently on antiretroviral therapy via US-supported programmes," the Ambassador said.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".

"The proposal required Zimbabwe to provide its genetic material and health information for a long time, with no corresponding assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.

"Put simply, our nation would supply the basic resources for scientific discovery with no assurance that the final treatments would be accessible to our population if a new disease outbreak emerge."

Sovereignty and Global Health

Mangwana further pointed out that the American exit from the global health body and its pursuit of one-on-one health agreements were disrupting systems already set up via the international health agency.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to manage future global health emergencies.

"This mechanism is intended to ensure that when a country contributes its data, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised solely by those with the funds to develop them."

The government's concerns over the US deal "should not be misconstrued as opposition to America," he added.

"We welcome continued discussions with our American counterparts on how subsequent collaboration could be arranged in a manner that honours the independence and dignity of both nations."

Health Experts Reaction

A leading public health body said it acknowledged the government's concerns, but recommended that talks should continue considering a large portion of the nation's HIV programmes relied on external financing.

"If specific concerns exist, including those involving data governance or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," the group commented.

The situation underscores the continuing debate between accepting vital foreign assistance and safeguarding local interests in an increasingly data-driven world.

BJ
About the author

Brianna Johnson

A tech journalist with over a decade of experience covering consumer electronics and emerging technologies across Europe.

PowerCore Vault

Type to search articles.